CU20100102A7 - VAGINAL ADMINISTRATION SYSTEM - Google Patents
VAGINAL ADMINISTRATION SYSTEMInfo
- Publication number
- CU20100102A7 CU20100102A7 CU20100102A CU20100102A CU20100102A7 CU 20100102 A7 CU20100102 A7 CU 20100102A7 CU 20100102 A CU20100102 A CU 20100102A CU 20100102 A CU20100102 A CU 20100102A CU 20100102 A7 CU20100102 A7 CU 20100102A7
- Authority
- CU
- Cuba
- Prior art keywords
- drospirenone
- membrane
- estrogen
- core
- compartment
- Prior art date
Links
Abstract
La presente invención se refiere a un sistema de administración intravaginal para la liberación controlada de drospirenona y un estrógeno y, opcionalmente, también comprende una o más sustancias terapéuticamente activas o promotoras de la salud capaces de brindar y/o mejorar la protección contra infecciones bacterianas y fúngicas, y/o mejorar la protección contra enfermedades de transmisión sexual. El sistema de administración comprende uno o más compartimientos, cada uno de los cuales comprende un núcleo y una membrana que recubre el núcleo, dicho núcleo y dicha membrana están compuestos esencialmente por la misma composición de polímero o una composición de polímero diferente, donde al menos un compartimiento comprende drospirenona y al menos un compartimiento, que puede ser igual o diferente del que comprende drospirenona, comprende un estrógeno o una mezcla de drospirenona y un estrógeno, y donde la membrana o la superficie de la membrana o al menos uno de los núcleos comprende dicha sustancia terapéuticamente activa o promotora de la salud.The present invention relates to an intravaginal administration system for the controlled release of drospirenone and an estrogen and, optionally, also comprises one or more therapeutically active or health promoting substances capable of providing and / or improving protection against bacterial infections and fungal, and / or improve protection against sexually transmitted diseases. The delivery system comprises one or more compartments, each of which comprises a core and a membrane covering the core, said core and said membrane are essentially composed of the same polymer composition or a different polymer composition, where at least A compartment comprises drospirenone and at least one compartment, which may be the same or different from that comprising drospirenone, comprises an estrogen or a mixture of drospirenone and an estrogen, and where the membrane or membrane surface or at least one of the nuclei It comprises said therapeutically active substance or health promoter.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20100102A CU20100102A7 (en) | 2010-05-24 | 2010-05-24 | VAGINAL ADMINISTRATION SYSTEM |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20100102A CU20100102A7 (en) | 2010-05-24 | 2010-05-24 | VAGINAL ADMINISTRATION SYSTEM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20100102A7 true CU20100102A7 (en) | 2011-10-14 |
Family
ID=45000090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20100102A CU20100102A7 (en) | 2010-05-24 | 2010-05-24 | VAGINAL ADMINISTRATION SYSTEM |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20100102A7 (en) |
-
2010
- 2010-05-24 CU CU20100102A patent/CU20100102A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP10010104A (en) | VAGINAL ADMINISTRATION SYSTEM | |
| CO6771417A2 (en) | Lysophosphatidic acid receptor antagonists and their use in the treatment of fibrosis | |
| UY32923A (en) | POLYCHYCLICAL COMPOUNDS AS ANTAGONISTS OF THE LISOPHOSPHATIDIC ACID RECEPTOR | |
| DK201470535A (en) | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof | |
| WO2015106128A3 (en) | Rnai agents modified at the 4'-c-position | |
| WO2010011609A3 (en) | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | |
| IN2012DN02735A (en) | ||
| PE20160680A1 (en) | PHARMACOLOGICAL ADMINISTRATION SYSTEM | |
| IN2012DN00754A (en) | ||
| MX2019003467A (en) | Formulations and methods for vaginal delivery of antiprogestins. | |
| CL2008000434A1 (en) | COMPOUNDS DERIVED FROM 2-AMINO-OXAZOLINAS; OBTAINING PROCESS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DEPRESSION, ANXIETY, STRESS, BIPOLAR DISORDER, AMONG OTHERS. | |
| MX2011009847A (en) | Anthelmintic agents and their use. | |
| MX2016002408A (en) | Treatment of pediatric otic disorders. | |
| ES2429422R1 (en) | Pharmaceutical composition and its use to prepare a medicine for the treatment and prevention of HIV diseases | |
| EA026830B9 (en) | Osmotically active vaginal delivery system | |
| CO7111317A2 (en) | Method for the treatment of gynecological diseases | |
| CU20100102A7 (en) | VAGINAL ADMINISTRATION SYSTEM | |
| CL2009000878A1 (en) | Sulfonamide derived compounds; pharmaceutical composition; and use in the treatment of diseases such as pain, migraine, diabetes, respiratory tract diseases, inflammatory bowel diseases, obesity, among others. | |
| WO2011049954A3 (en) | Compositions comprising wnt modulators or neurotoxins for the treatment of otic disorders | |
| Kennedy | Flucloxacillin/voriconazole interaction | |
| CL2008000671A1 (en) | Compounds derived from 3-cyano-4- (4-tetrahydropyran-phenyl) -pyridin-2-one; Preparation process; pharmaceutical composition; and use in the treatment of diseases such as anxiety, migraine, epilepsy, among others. | |
| CL2008000672A1 (en) | Compounds derived from 3-cyano-4- (4-pyridinyloxy-phenyl) -pyridin-2-one; Preparation process; pharmaceutical composition; and use in the treatment of diseases such as anxiety, migraine, epilepsy, among others. | |
| UA93098C2 (en) | Liposomal antihelminth agent based on fenasal | |
| UA42862U (en) | USE OF SOFT DRUG DOSAGE FORM CONTAINING β-PHENYLETHYLAMIDE OF 2-OXYSUCCINANILIC ACID AS AN ACTIVE SUBSTANCE FOR TREATMENT OF SKIN BURN |